Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.
about
How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferCloning and expression of human membrane-bound and soluble engineered T cell receptors for immunotherapy.TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells.Cytokine-induced NK-like T cells: from bench to bedside.Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot studyDirected differentiation of induced pluripotent stem cells towards T lymphocytes.Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.Costimulation with anti-cluster of differentiation 3 and anti-cluster of differentiation 28 reduces the activity of mucin 1-stimulated human mononuclear cells.Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer.Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialA role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.Hematopoietic stem cells for cancer immunotherapyEnhanced T cell receptor gene therapy for cancer.MUC1 immunotherapy.MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles.Tucaresol down-modulation of MUC1-stimulated human mononuclear cells.
P2860
Q28727481-ADAE011F-4598-42E4-A9E6-3F4F89C3BE2AQ30446191-6F38C5EA-C03C-451E-87D9-2A66D890BD62Q33727779-CAAE8E9E-414C-40B2-A61D-E42DE12B73C4Q33762499-2C3599B1-653F-46FE-86FB-E05D5712FF38Q35747569-9E6B206C-7018-499D-8FE6-A834E0F7F07CQ36076969-57F1F434-11BB-497A-9744-65A6DEFD6C12Q36178641-7ECFF796-30E1-4A55-9AAE-77530E4A46BEQ36386316-C744DFF8-3513-4648-A6E9-643A8FE69CA8Q36519394-6B2D236B-30AF-47EA-A143-0D41EE0E209BQ36694948-6C26FBB8-20AD-48C1-91E7-3E12D5D30B6EQ37193096-215C3704-A2F4-4BED-8FAF-8E53C8CBA355Q37376346-851A05C0-DB12-49A2-815D-80FCBC59C08FQ37512048-E5887483-F3B4-4B57-85F7-3983CD92E51DQ37702226-6322FD42-9561-4F0C-97D0-17826B9C00EDQ37773241-2894630F-E9F8-4DA9-907B-0682D4F89D07Q39994977-6B31393C-61C9-4D99-A078-4CA734324F57Q41903428-9838E5F3-306A-4EA2-B58F-00EB3BC7ACE2Q44995384-1C2FF980-13DE-4E40-AE0D-34655178B776
P2860
Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Therapeutic potential of a tum ...... ion and immune reconstitution.
@ast
Therapeutic potential of a tum ...... ion and immune reconstitution.
@en
type
label
Therapeutic potential of a tum ...... ion and immune reconstitution.
@ast
Therapeutic potential of a tum ...... ion and immune reconstitution.
@en
prefLabel
Therapeutic potential of a tum ...... ion and immune reconstitution.
@ast
Therapeutic potential of a tum ...... ion and immune reconstitution.
@en
P2093
P2860
P1433
P1476
Therapeutic potential of a tum ...... tion and immune reconstitution
@en
P2093
Jan Schmielau
Mark D Alter
Michael Cascio
Olivera J Finn
P2860
P304
P356
10.1182/BLOOD-2004-10-3848
P407
P577
2005-03-03T00:00:00Z